Is Indomethacin Extended Release Capsules, 75 mg.; an Rx oral nonsteroidal anti-inflammatory; Packaged by Allscripts, Libertyville, IL 60045, Manufactured by Able Laboratories; the capsules were packaged in the following configurations: Product no. 1518-0: 30 capsules, Product no. 1518-2: 14 capsules, Product no. 1518-3: 20 capsules; NDC #53265-0269-10 recalled?

Medium RiskFDA Drug

Allscripts LLC: Allscripts repackaged products being recalled by the manufacturer, Able Laboratories, due to a lack of assurance that testing conducted for release and stability conformed to standard operating procedures.

Agency Publication Date: July 8, 2005

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 32266

Status: Active

Manufacturer: Allscripts LLC

Manufactured In: United States

Units Affected: 8 products (10,828 capsules; 48,134 tablets; 8,808 suppositories; 17,372 tablets; 158,832 tablets; 3,168 suppositories; 1,848 tablets; 54,270 tablets)

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.